2019. Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S26. DOI:https://doi.org/10.25251/skin.3.supp.26.